Morphological analysis of human umbilical vein endothelial cells co-cultured with ovarian cancer cells in 3D: an oncogenic angiogenesis assay
Antiangiogenic therapy for cancer is a strategy targeted at tumour vasculature, often in combination with conventional cytotoxicity treatments. Animal testing is still the most common method used for evaluating the efficacy of new drugs but tissue-engineered in vitro models are becoming more accepta...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Public Library of Science
2017
|
| _version_ | 1797071460107288576 |
|---|---|
| author | Wan, X Bovornchutichai, P Cui, Z O'Neill, E Ye, H |
| author_facet | Wan, X Bovornchutichai, P Cui, Z O'Neill, E Ye, H |
| author_sort | Wan, X |
| collection | OXFORD |
| description | Antiangiogenic therapy for cancer is a strategy targeted at tumour vasculature, often in combination with conventional cytotoxicity treatments. Animal testing is still the most common method used for evaluating the efficacy of new drugs but tissue-engineered in vitro models are becoming more acceptable for replacing and reducing the use of animals in anticancer drug screening. In this study, a 3D co-culture model of human endothelial cells and ovarian cancer cells was developed. This model has the potential to mimic the interactions between endothelial cells and ovarian cancer cells. The feasibility of applying this model in drug testing was explored here. The complex morphology of the co-culture system, which features development of both endothelial tubule-like structures and tumour structures, was analysed quantitatively by an image analysis method. The co-culture morphology integrity was maintained for 10 days and the potential of the model for anti-cancer drug testing was evaluated using Paclitaxel and Cisplatin, two common anti-tumour drugs with different mechanisms of action. Both traditional cell viability assays and quantitative morphological analyses were applied in the drug testing. Cisplatin proved a good example showing the advantages of morphological analysis of the co-culture model when compared with mono-culture of endothelial cells, which did not reveal an inhibitory effect of Cisplatin on the tubule-like endothelial structures. Thus, the tubule areas of the co-culture reflected the anti-angiogenesis potential of Cisplatin. In summary, in vitro cancer models can be developed using a tissue engineering approach to more closely mimic the characteristics of tumours in vivo. Combined with the image analysis technique, this developed 3D co-culture angiogenesis model will provide more reproducible and reliably quantified results and reveal further information of the drug’s effects on both tumour cell growth and tumour angiogenesis. |
| first_indexed | 2024-03-06T22:53:34Z |
| format | Journal article |
| id | oxford-uuid:5f9d10be-f42d-4600-80a6-7de2cec096f9 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T22:53:34Z |
| publishDate | 2017 |
| publisher | Public Library of Science |
| record_format | dspace |
| spelling | oxford-uuid:5f9d10be-f42d-4600-80a6-7de2cec096f92022-03-26T17:48:02ZMorphological analysis of human umbilical vein endothelial cells co-cultured with ovarian cancer cells in 3D: an oncogenic angiogenesis assayJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5f9d10be-f42d-4600-80a6-7de2cec096f9Symplectic Elements at OxfordPublic Library of Science2017Wan, XBovornchutichai, PCui, ZO'Neill, EYe, HAntiangiogenic therapy for cancer is a strategy targeted at tumour vasculature, often in combination with conventional cytotoxicity treatments. Animal testing is still the most common method used for evaluating the efficacy of new drugs but tissue-engineered in vitro models are becoming more acceptable for replacing and reducing the use of animals in anticancer drug screening. In this study, a 3D co-culture model of human endothelial cells and ovarian cancer cells was developed. This model has the potential to mimic the interactions between endothelial cells and ovarian cancer cells. The feasibility of applying this model in drug testing was explored here. The complex morphology of the co-culture system, which features development of both endothelial tubule-like structures and tumour structures, was analysed quantitatively by an image analysis method. The co-culture morphology integrity was maintained for 10 days and the potential of the model for anti-cancer drug testing was evaluated using Paclitaxel and Cisplatin, two common anti-tumour drugs with different mechanisms of action. Both traditional cell viability assays and quantitative morphological analyses were applied in the drug testing. Cisplatin proved a good example showing the advantages of morphological analysis of the co-culture model when compared with mono-culture of endothelial cells, which did not reveal an inhibitory effect of Cisplatin on the tubule-like endothelial structures. Thus, the tubule areas of the co-culture reflected the anti-angiogenesis potential of Cisplatin. In summary, in vitro cancer models can be developed using a tissue engineering approach to more closely mimic the characteristics of tumours in vivo. Combined with the image analysis technique, this developed 3D co-culture angiogenesis model will provide more reproducible and reliably quantified results and reveal further information of the drug’s effects on both tumour cell growth and tumour angiogenesis. |
| spellingShingle | Wan, X Bovornchutichai, P Cui, Z O'Neill, E Ye, H Morphological analysis of human umbilical vein endothelial cells co-cultured with ovarian cancer cells in 3D: an oncogenic angiogenesis assay |
| title | Morphological analysis of human umbilical vein endothelial cells co-cultured with ovarian cancer cells in 3D: an oncogenic angiogenesis assay |
| title_full | Morphological analysis of human umbilical vein endothelial cells co-cultured with ovarian cancer cells in 3D: an oncogenic angiogenesis assay |
| title_fullStr | Morphological analysis of human umbilical vein endothelial cells co-cultured with ovarian cancer cells in 3D: an oncogenic angiogenesis assay |
| title_full_unstemmed | Morphological analysis of human umbilical vein endothelial cells co-cultured with ovarian cancer cells in 3D: an oncogenic angiogenesis assay |
| title_short | Morphological analysis of human umbilical vein endothelial cells co-cultured with ovarian cancer cells in 3D: an oncogenic angiogenesis assay |
| title_sort | morphological analysis of human umbilical vein endothelial cells co cultured with ovarian cancer cells in 3d an oncogenic angiogenesis assay |
| work_keys_str_mv | AT wanx morphologicalanalysisofhumanumbilicalveinendothelialcellscoculturedwithovariancancercellsin3danoncogenicangiogenesisassay AT bovornchutichaip morphologicalanalysisofhumanumbilicalveinendothelialcellscoculturedwithovariancancercellsin3danoncogenicangiogenesisassay AT cuiz morphologicalanalysisofhumanumbilicalveinendothelialcellscoculturedwithovariancancercellsin3danoncogenicangiogenesisassay AT oneille morphologicalanalysisofhumanumbilicalveinendothelialcellscoculturedwithovariancancercellsin3danoncogenicangiogenesisassay AT yeh morphologicalanalysisofhumanumbilicalveinendothelialcellscoculturedwithovariancancercellsin3danoncogenicangiogenesisassay |